Qiagen.com

(IN BRIEF) QIAGEN is organizing the Global TB Clinical and Educational Summit 2023, running from October 17-19, with the theme “Tackling TB together: From awareness to action.” This summit highlights QIAGEN’s dedication to combat tuberculosis (TB) and address the gap … Read the full press release →

(IN BRIEF) QIAGEN has launched the QIAseq Normalizer Kits, a new solution for researchers to efficiently pool different DNA libraries for optimal results in next-generation sequencing (NGS) runs. The kit accelerates the process of normalizing DNA concentrations across libraries, reducing … Read the full press release →

(IN BRIEF) QIAGEN has entered into a partnership with global pharmaceutical group, Servier, to develop a companion diagnostic test for TIBSOVO, an isocitrate dehydrogenase-1 (IDH1) inhibitor used to treat acute myeloid leukemia (AML). QIAGEN will develop and validate a real-time … Read the full press release →